News
SK Capital Partners has hired Michael Gilbert as a managing director, head of portfolio operations. Prior to joining SK Capital, Gilbert was the CEO of Aristech Surfaces. New York, March 7, 2022 ...
Why did two private equity firms with more than $460 billion under management want a little old gene therapy biotech called ...
SK Capital focuses on the specialty materials, specialty chemicals, and pharmaceuticals sectors. Currently, SK Capital has approximately $6.6 billion of assets under management.
RBC Capital Markets, Scotiabank, Jefferies LLC and Deutsche Bank Securities Inc. served as financial advisors to SK Capital and Kirkland & Ellis and McMillan LLP served as legal counsel.
SK Capital aims to utilize its industry, operating and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic ...
SK Capital Managing Director Jack Norris, who oversees materials and chemicals investments, said his company is providing a "capital structure for Milestone that enables it to execute its strategy." ...
SK Capital’s portfolio of businesses generates revenues of approximately $12 billion annually, employs more than 25,000 people globally, and operates more than 200 plants in over 30 countries.
SK Capital Partners is acquiring the fire safety and oil additives businesses of minerals and chemicals company Israel Chemicals Ltd. for about $1 billion. The New York firm said it sees ...
SK Capital Partners is considering a sale of Geon Performance Solutions that could value the chemical maker at about $2 billion, according to people with knowledge of the matter.
SK Capital Partners is in talks to acquire Swiss chemical giant Clariant AG’s pigments business, according to people familiar with the matter, potentially bringing an end to a lengthy sales ...
The investment firm SK Capital Partners has sold Foremark Performance Chemicals to the family-owned company CC Industries for an undisclosed sum. Based in League City, Texas, ...
SK Capital Partners, a firm focused on the specialty material, chemical and health-care sectors, opted to follow its own formula while raising its latest, and largest, fund, which closed at its $1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results